系统性免疫炎症指数,静脉注射用免疫球蛋白,无反应型,川崎病,风险因素,预测模型,列线图 ," /> 系统性免疫炎症指数,静脉注射用免疫球蛋白,无反应型,川崎病,风险因素,预测模型,列线图 ,"/> Systemic immune-inflammation index,Intravenous immunoglobulin,Non-reactive type,Kawasaki disease,Risk factors,Prediction model,Nomogram ,"/> <div> <span style="font-size:14px;line-height:2;">基于外周血 SII 的静脉注射用免疫球蛋白无反应型川崎病风险预测模型构建</span> </div>
Please wait a minute...
欢迎访问发育医学电子杂志,今天是
发育医学电子杂志  2026, Vol. 14 Issue (5): 420-427    DOI: 10.3969/j.issn.2095-5340.2026.05.007
  生长发育   论著 |
基于外周血 SII 的静脉注射用免疫球蛋白无反应型川崎病风险预测模型构建
刘俊艳 张立华 信艺 王静
1. 衡水市中医医院 检验科,河北 衡水 053000 ;2. 滨州医学院 第二临床医学院,山东 滨州 056603
Construction of a risk prediction model for intravenous immunoglobulin non-reactive type Kawasaki disease based on peripheral blood systemic immune-inflammation index
Liu Junyan, Zhang Lihua, Xin Yi, et al
1.Department of Laboratory, Hengshui Hospital of Traditional Chinese Medicine, Hengshui, Hebei 053000, China; 2.Second Clinical College of Binzhou Medical University, Binzhou, Shandong 056603, China
下载:  PDF (1251KB) 
输出:  BibTeX | EndNote (RIS)      
摘要 
目的 分析基于外周血系统性免疫炎症指数(systemic immune-inflammation index,SII)的静脉注射用免疫球蛋白(intravenous immunoglobulin, IVIG)无反应型川崎病(Kawasaki disease,KD)的风险因素,并构建其列线图预测模型。方法 采用前瞻性研究方法,选取 2022 年 1 月至 2024 年 1 月衡水市中医医院收治的 200 例 KD 患儿,根据是否存在 IVIG 无反应型 KD,将 49 例 IVIG 无反应型 KD 患儿设为观察组,将 151 例非 IVIG 无反应型 KD 患儿设为对照组,总样本按 7 ∶ 3 分为建模集(n=147)和验证集(n=53)。比较观察组和对照组患者的 SII、发热时间、C 反应蛋白(C-reactive protein,CRP)、N 末端 B 型利钠肽原(N-terminal pro-B-type natriuretic peptide,NT-proBNP)以及一般资料,采用多因素 Logistic 回归分析探讨 IVIG 无反应型 KD 发生的危险因素,通过 R 3.6.3 软件构建列线图预测模型,以 Bootstrap 法进行内部验证,以验证集进行外部验证。采用受试者工作特征(receiver operating characteristic,ROC)曲线、决策曲线分析(decision curve analysis,DCA)评估 SII 对 IVIG 无反应型 KD 的预测效能。统计学分析采用独立样本 t 检验和 χ2 检验。结果 观察组的发热时间、CRP、NT-proBNP, SII 均高于对照组 [(5.01±0.98)d与(4.01±0.92)d,(28.66±6.91) mg/L 与(20.46±4.16) mg/L,(1 782.62±128.66)ng/L 与(998.62±82.64)ng/L,

619.52±52.66 与 452.62±30.07],白蛋白(albumin,ALB)低于对照组 [(33.26±1.45) g/L 与(41.62±

2.84) g/L],差异均有统计学意义(t 值分别为 6.506、10.038、49.752、27.555、19.763,P值均 <0.001)。多因素 Logistic 回归分析结果显示,SII(OR=2.137,95% CI:1.052~4.482)、发热时间(OR=1.979,95% CI:1.130~3.433)、CRP(OR=2.657,95% CI :1.288~3.581)、NT-proBNP(OR=3.957,95% CI :1.384~5.270)是发生 IVIG 无反应型 KD 的危险因素,ALB(OR=0.476,95% CI :0.257~0.912)是保护因素(P 值均 <0.05)。SII+ 发热时间 +CRP+ALB+NT-proBNP 预测模型外部验证 C 统计量是 0.854(95% CI :0.781~0.923),预测发生风险与实际情况一致性较好,Brier 评分为 0.142。C 统计量为 0.914,说明 SII+ 发热时间 +CRP+ALB+NT-proBNP 预测模型在预测 IVIG 无反应型 KD 发生的区分能力较好。SII+ 发热时间 +CRP+ALB+NT-proBNP 预测模型曲线下面积(area under the curve,AUC)为 0.914(95% CI :0.838~

0.940),提示判别能力、预测价值高。ROC 曲线分析结果显示,SII 预测 IVIG 无反应型 KD 的 AUC 值为 0.859(95% CI :0.813~0.947),敏感度为 92.84%,特异度为 82.26%。结论 SII 异常增高与 IVIG 无反应型 KD 的发生联系密切,SII 对 IVIG 无反应型 KD 具有较高的预测效能。

服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词:  系统性免疫炎症指数')" href="#">    
Abstract: 
Objective To analyze the risk factors of intravenous immunoglobulin (IVIG) non-reactive type Kawasaki disease (KD) based on peripheral blood systemic immune-inflammation index (SII), and construct a
nomogram prediction model. Methods A prospective study was conducted. Two hundred children with KD
admitted to Hengshui Hospital of Traditional Chinese Medicine from January 2022 to January 2024 were
selected. According to whether there was IVIG non-reactive type KD, 49 children with IVIG non-reactive
type KD were set as the observation group. and 151 children with non-IVIG non-reactive type KD were set
as the control group. The total sample was divided into modeling sets (n=147) and verification sets (n=53)
in a 7∶3 ratio. The SII, fever duration C-reactive protein (CRP), N-terminal pro-B-type natriuretic peptide
(NT-proBNP) and general data of children in the observation group and the control group were compared.
Multivariate Logistic regression was used to analyze the risk factors for the occurrence of IVIG non-reactive type KD. A nomogram prediction model was constructed through R 3.6.3 software. Internal validation was conducted using the Bootstrap method, and external validation was performed using the validation set. The receiver operating characteristic (ROC) curve and decision curve analysis (DCA) were used to analyze the predictive efficacy of SII for IVIG non-reactive type KD. Statistical analyses were performed using independent sample t-test and χ2 test. Results The fever duration, CRP, NT-proBNP and SII in the observation group were all higher than those in the control group [(5.01±0.98) d vs (4.01±0.92) d, (28.66±6.91) mg/L vs (20.46±4.16) mg/L, (1 782.62±128.66) ng/L vs (998.62±82.64) ng/L, 619.52±52.66 vs 452.62±30.07], while the albumin (ALB) level was lower than that in the control group [(33.26±1.45) g/L vs (41.62±2.84) g/L], and the differences were statistically significant (t values were 6.506, 10.038, 49.752, 27.555, 19.763, respectively, all P<0.05). Multivariate Logistic regression analysis showed that SII (OR=2.137, 95% CI: 1.052-4.482), fever duration (OR=1.979, 95% CI: 1.130-3.433), CRP (OR=2.657, 95% CI: 1.288-3.581), and NT-proBNP (OR=3.957, 95% CI: 1.384-5.270) were risk factors for the occurrence of IVIG non-reactive type KD, ALB (OR=0.476, 95% CI: 0.257-0.912) was the protective factor (all P<0.05). The external validation C-index of the SII+fever duration+CRP+ALB+NT-proBNP prediction model was 0.854 (95% CI: 0.781-0.923), the predicted risk of occurrence was in good agreement with the actual situation, and the Brier score was 0.142. The C-index was 0.914, indicating that the SII+fever duration+CRP+ALB+NT-proBNP prediction model had a better discriminatory ability in predicting the occurrence of IVIG non-reactive type KD. The area under the curve (AUC) of the SII+fever duration +CRP+ALB+NT-proBNP prediction model was 0.914 (95% CI: 0.838-0.940), with high discriminative ability and predictive value. ROC curve analysis showed that the AUC of SII for predicting IVIG non-reactive type KD was 0.859 (95% CI: 0.813-0.947), with a sensitivity of 92.84%, and a specificity of 82.26%. Conclusions The abnormal increase of SII is closely related to the occurrence of IVIG non-reactive type KD, and SII has a high predictive efficacy for IVIG non-reactive type KD.
Key words:  Systemic immune-inflammation index')" href="#">
收稿日期:  2025-04-22                出版日期:  2026-09-30      发布日期:  2026-09-30      期的出版日期:  2026-09-30
基金资助: 
河北省重点研发计划项目(21008310219D)
通讯作者:  刘俊艳    E-mail:  jia766136@163.com
引用本文:    
刘俊艳 张立华 信艺 王静.
基于外周血 SII 的静脉注射用免疫球蛋白无反应型川崎病风险预测模型构建
[J]. 发育医学电子杂志, 2026, 14(5): 420-427.
Liu Junyan, Zhang Lihua, Xin Yi, et al.
Construction of a risk prediction model for intravenous immunoglobulin non-reactive type Kawasaki disease based on peripheral blood systemic immune-inflammation index
. Journal of Developmental Medicine(Electronic Version), 2026, 14(5): 420-427.
链接本文:  
http://www.fyyxzz.com/CN/10.3969/j.issn.2095-5340.2026.05.007  或          http://www.fyyxzz.com/CN/Y2026/V14/I5/420
[1] 谢巧庆 何春梅 罗美 黄科志 李智英 李容丹.
妊娠期糖尿病产妇分娩的新生儿低血糖风险预测模型的系统评价
[J]. 发育医学电子杂志, 2026, 14(5): 398-405.
[2] 张 佳 宋 宴 宏  陈 剑. 新生儿高胆红素血症预测模型的构建和验证[J]. 发育医学电子杂志, 2026, 14(1): 51-57.
[3] 宝 凌 云  李 明 盼  李 佳 欣. 胎龄≤ 32 周早产儿支气管肺发育不良危险因素分析及预测模型构建[J]. 发育医学电子杂志, 2025, 13(5): 358-365.
[4] 周菊梅 雷斐 刘新美 王少丽. 妊娠期高血压综合征孕妇低分子肝素联合小剂量阿司匹林治疗后出现不良妊娠结局的危险因素及风险预测模型[J]. 发育医学电子杂志, 2025, 13(3): 195-201.
[5] 曹旭峰 牛海燕 卫炜 隋超 张宁 苏莉莉. 左心室压力- 应变环评估川崎病患儿左心室收缩功能的定量研究[J]. 发育医学电子杂志, 2024, 12(2): 108-113.
[6] 吴志荣 朱玉平 万丽娟. 产后盆底功能障碍康复治疗效果的影响因素及列线图预测模型建立[J]. 发育医学电子杂志, 2023, 11(3): 187-193.
[7] 杨燕飞 张丽萍. 心率变异性指标和中性粒细胞与淋巴细胞比值对小儿川崎病并发冠状动脉病变的诊断价值[J]. 发育医学电子杂志, 2022, 10(3): 174-181.
[8] 宋文惠 杨孜. 先天性肾上腺皮质增生高风险成功妊娠1例分析并文献复习[J]. 发育医学电子杂志, 2014, 2(2): 106-110.
No Suggested Reading articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed